Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment

See also
Status	Clinical Trial	Phase
Completed	`NCT03859609` - Comparison of GAP-score With Schwab-score
Recruiting	`NCT06029764` - Extended One-level Interbody Fusion for Adjacent Vacuum Phenomenon in Lumbar Degenerative Disc Disease	N/A
Completed	`NCT03477955` - PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03859609 - Comparison of GAP-score With Schwab-score

Recruiting

NCT06029764 - Extended One-level Interbody Fusion for Adjacent Vacuum Phenomenon in Lumbar Degenerative Disc Disease

N/A

Completed

NCT03477955 - PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04970862
Study type	Observational
Source	Peking University Third Hospital
Contact	Weishi Li, M.D.
Phone	(+86010)62017691-7011
Email	puh3liweishi@163.com
Status	Not yet recruiting
Phase
Start date	August 1, 2021
Completion date	December 30, 2023

Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms